Clarkston Consulting
Skip to content

2016 Life Sciences Outlook

While increased healthcare spend will likely lead to higher revenues for manufacturers, life sciences companies will focus heavily on addressing regulatory requirements, industry and consumer influences, pricing, and demonstrating comprehensive therapeutic value. Companies that successfully leverage technological advances, partnerships with industry organizations and academia, and internal resources will see a definite impact throughout the value chain.

Click through to read the 2016 Life Sciences Outlook report which includes key trends that pharmaceutical, biotechnology, and medical device manufacturers will need to consider and address in the coming year, along with strategic guidance for each.

Tags: Competitive Differentiation & Execution, Post M&A Integration